Daphne Karydas - 13 Feb 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MLYS	Stock Option	Award	$0	+32,900		$0.000000	32,900	13 Feb 2025	Common Stock	32,900	$10.20	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests in 12 substantially equal monthly installments following the date of grant.